NCT04446897

Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction

Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction Immobilised on a Biodegradable Carrier

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus · Other Government
• Sex: All
• Age: 70 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Treatment of chronic medium-severe periodontitis with mesenchymal stem cells and mesenchymal stem cells predifferentiated in osteogenic direction

Detailed description

The bone defect will be filled with a porous membrane based on bone collagen measuring 5x5 mm or more with mesenchymal stem cells and mesenchymal stem cells predifferentiated in osteogenic direction

Conditions

• Periodontitis, Chronic

Interventions

Type	Name	Description
BIOLOGICAL	mesenchymal stem cells	autologous mesenchymal stem cells
OTHER	standard treatment	standard treatment according to clinical protocols

Timeline

• Start date: 2020-08-03
• Primary completion: 2020-12-31
• Completion: 2020-12-31
• First posted: 2020-06-25
• Last updated: 2021-02-09

Locations

1 site across 1 country: Belarus